Evaluation of the Prevalence Rate and the Prognostic Effect of Human Papilloma Virus Infection in a Group of Patients With Oral Cavity Squamous Cell Carcinoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27703640)

Published in Iran J Cancer Prev on April 25, 2016

Authors

Nasrollah Saghravanian1, Maryam Zamanzadeh2, Zahra Meshkat3, Monavar Afzal Aghaee4, Roham Salek5

Author Affiliations

1: Department of Oral and Maxillofacial Pathology, Dental Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran.
2: Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, IR Iran.
3: Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran.
4: Department of Community Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran.
5: Clinical Radiation Oncology, Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran.

Articles cited by this

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77

Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer (2007) 3.98

Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer (2001) 2.35

Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer (2000) 2.17

HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol (2008) 1.99

Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol (2012) 1.81

HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer (2007) 1.80

Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer (1997) 1.71

HPV & head and neck cancer: a descriptive update. Head Neck Oncol (2009) 1.60

Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res (2002) 1.53

Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol (2012) 1.45

Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res (1996) 1.44

The role of human papillomavirus infection in head and neck cancers. Ann Oncol (2010) 1.43

The role of human papillomavirus in head and neck cancer. APMIS (2010) 1.39

Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev (2011) 1.36

Human papillomavirus and risk of oral cancer. Laryngoscope (1998) 1.32

Human papillomavirus detection in head and neck squamous cell carcinomas. Adv Anat Pathol (2010) 1.29

Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol (2012) 1.27

Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett (2005) 1.22

Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. Br J Oral Surg (1983) 1.17

HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol (2007) 1.13

Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett (2007) 1.07

Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer (2002) 1.06

Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx. Braz J Otorhinolaryngol (2006) 1.06

Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol (2009) 1.04

Human papillomavirus and oropharyngeal cancer: what you need to know in 2009. Curr Treat Options Oncol (2009) 1.04

The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview. Infect Agent Cancer (2011) 1.04

Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol (2007) 1.00

Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer (1996) 0.98

Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol (2009) 0.97

HPV-related squamous cell carcinoma variants in the head and neck. Head Neck Pathol (2012) 0.95

Human papillomavirus 6/11, 16 and 18 in oral carcinomas and benign oral lesions. Med Microbiol Immunol (2002) 0.94

Human papillomavirus-16 in oral squamous cell carcinoma: clinical correlates and 5-year survival. Br J Oral Maxillofac Surg (2006) 0.92

New concepts on the role of human papillomavirus in cell cycle regulation. Ann Med (1999) 0.92

High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer (2011) 0.92

Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene (1996) 0.91

Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 0.90

Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper. Mod Pathol (2008) 0.89

In situ hybridization analysis of human papillomavirus DNA in oral mucosal lesions. Oral Surg Oral Med Oral Pathol (1991) 0.89

Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association. Oncology (2002) 0.85

HPV detection using "hot start" polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol (1994) 0.85

Human papillomavirus subtypes in oral lesions compared to healthy oral mucosa. J Clin Virol (2012) 0.85

In situ DNA hybridization analysis of oral papillomas, leukoplakias, and carcinomas for human papillomavirus. Oral Surg Oral Med Oral Pathol (1991) 0.85

Human papillomavirus (HPV) related carcinomas of the upper aerodigestive tract. Head Neck Pathol (2007) 0.83

The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases. Virchows Arch (2011) 0.83

Recent data about the role of human papillomavirus (HPV) in oncogenesis of head and neck cancer. Rom J Morphol Embryol (2010) 0.79

TP53 gene expression in HPV-positive oral tongue SCC and its correlation with nodal metastasis. Pathol Res Pract (2011) 0.78

Incidence of low risk human papillomavirus in oral cancer: a real time PCR study on 278 patients. Int J Immunopathol Pharmacol (2011) 0.77

HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients. Oncol Lett (2012) 0.77